Last update:

Oncology & Cancer news

Oncology & Cancer

Researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, Ph.D., Chair of Cleveland Clinic's Global Center for Immunotherapy, and Bristol Myers Squibb has published the most comprehensive overview to date of ...

Oncology & Cancer

Scientists develop new model for ovarian cancer, with crossover to uterine cancer

Most uterine cancers have excellent five-year survival rates—up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer.

Oncology & Cancer

Categorizing the epigenetic hallmarks that define cancer

Cancer mortality has just surpassed cardiovascular disease for the first time ever and one in two men, and one in three women, will be diagnosed with some form of the disease in the US, according to the NIH.

Medications

New book explores the history of the phony cancer drug Krebiozen

In March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—held a press conference in Chicago to announce Krebiozen, a recently discovered wonder drug that Ivy said could ...

Oncology & Cancer

Report explores the role alcohol plays in new cancer cases

A little bit of alcohol was once thought to be good for you. However, as scientific research advances, we're gaining a clearer picture of alcohol's effect on health—especially regarding cancer.

Oncology & Cancer

New drug combination shows promise for small cell lung cancer

Researchers at the Icahn School of Medicine at Mount Sinai have made a promising breakthrough in the treatment of small cell lung cancer (SCLC). Their study, published in Science Advances and titled "ATR Inhibition Activates ...

Oncology & Cancer

Scientists map the evolution of urinary tract cancer cells

Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC). The study, ...

Medications

Understanding what causes trastuzumab's cardiotoxicity

A new meta-analysis published in OMICS: A Journal of Integrative Biology helps shed light on how changes in mitochondria-related gene expression may cause the cardiotoxicity associated with the cancer therapy trastuzumab.

Oncology & Cancer

Assessing breast cancer risk

The genetic risk of breast cancer has been in the news lately. Researchers at the Mayo Clinic Comprehensive Cancer Center are working toward pinpointing individuals' risk of developing breast cancer.

Oncology & Cancer

Warning signs of colorectal cancer in younger adults

Colorectal cancer, the third-most common cancer in the U.S., has been rising among younger people for the past two decades. It is not one type of cancer but two cancers: colon cancer, which starts in the large intestine, ...

Oncology & Cancer

Advances in multiple myeloma treatment

March is Myeloma Awareness Month. Multiple myeloma is a blood cancer that most often occurs in people over age 45. It's the second-most common blood cancer and the most common blood cancer in Black people.

Oncology & Cancer

Researchers develop dual anti-tumor vaccine

A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has discovered that exosomes derived from γδ-T cells not only have direct anti-tumor effects but also, when developed into a tumor vaccine, ...

Oncology & Cancer

New AI model detects 90% of lymphatic cancer cases

Medical image analysis using AI has developed rapidly in recent years. Now, one of the largest studies to date has been carried out using AI-assisted image analysis of lymphoma, cancer of the lymphatic system. Researchers ...